Sodium valproate prescription to women of childbearing age in a New Zealand inpatient psychiatric unit
- 25 June 2020
- journal article
- research article
- Published by SAGE Publications in Australasian Psychiatry
- Vol. 28 (5) , 555-558
Abstract
Objective: Sodium valproate’s teratogenicity has prompted increasing restriction in its use. It is still widely prescribed to women of childbearing age in New Zealand. To examine this problem, we audited the prescribing pattern of sodium valproate in a psychiatric inpatient unit in New Zealand. Method: We reviewed the clinical records of women admitted over a 2-year period (2016–2018). Results were analysed and compared with local and international guidelines. Results: Five hundred and thirty-four women of child-bearing age were admitted over the sampling period, 96 of whom (18%) were prescribed valproate on discharge. Half of these patients had diagnoses other than bipolar affective disorder, valproate’s only approved psychiatric indication in New Zealand. Pregnancy testing and contraception status were documented in a minority (29 and 10 cases, respectively). Teratogenic risk discussion was documented in only 11 cases. Conclusions: Prescription of valproate to women of childbearing age in our sample currently falls well short of best practice. Urgent action at both clinician and organisational levels is required to address this risk.Keywords
This publication has 10 references indexed in Scilit:
- ‘Conceivably Neglected’ – Are prescribers sufficiently aware of the risks of prescribing sodium valproate to women with mental illness?Australasian Psychiatry, 2019
- Unplanned pregnancies in New ZealandAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2017
- Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disordersAustralian & New Zealand Journal of Psychiatry, 2015
- Brief report novel mechanism for valproate‐induced teratogenicityBirth Defects Research Part A: Clinical and Molecular Teratology, 2014
- Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepineArchives of Disease in Childhood, 2011
- Management issues for women with epilepsy—Focus on pregnancy (an evidence‐based review): II. Teratogenesis and perinatal outcomesEpilepsia, 2009
- Pregnancy outcomes in women with epilepsy: A systematic review and meta-analysis of published pregnancy registries and cohortsEpilepsy Research, 2008
- Defining the menopausal transitionThe American Journal of Medicine, 2005
- A survey of the off-label use of mood stabilizers in a large psychiatric hospitalJournal of Psychopharmacology, 2005
- Teratogenicity of sodium valproateExpert Opinion on Drug Safety, 2005